申请人:Acadia Pharmaceuticals Inc.
公开号:US08101651B2
公开(公告)日:2012-01-24
Disclosed herein are compounds of Formula I
as disclosed herein, methods of modulating the activity of an estrogen receptor and methods of treating a disorder associated with estrogen receptors.
本文公开了公式I的化合物,揭示了调节
雌激素受体活性的方法和治疗与
雌激素受体相关的疾病的方法。